Angiogenesis inhibitors in cancer - Clinical applications

Australian Prescriber

Volumn 29, Issue 1, 2006, Pages 13-15

  Mainwaring, Paul ^a  

^a MATER ADULT HOSPITAL   (Australia)

Author keywords

Bevacizumab; Colorectal cancer; Lung cancer

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; ANGIOGENESIS INHIBITOR; AVE 8062A; BEVACIZUMAB; CARBOPLATIN; COMBRETASTATIN; COMBRETASTATIN A1 PHOSPHATE; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOFLAXONE; MONOCLONAL ANTIBODY; N ACETYLCOLCHINOL PHOSPHATE; PACLITAXEL; PAZOPANIB; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; THALIDOMIDE; VANDETANIB; VASCULAR TARGETING AGENT; VATALANIB;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTERY THROMBOSIS; ATAXIA; BLEEDING; CANCER; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DESQUAMATION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FATIGUE; HEADACHE; HEMOPTYSIS; HUMAN; HYPERTENSION; HYPOTENSION; HYPOXIA; INTESTINE PERFORATION; KIDNEY CANCER; LUNG CANCER; LUNG NON SMALL CELL CANCER; NAUSEA AND VOMITING; NEOVASCULARIZATION (PATHOLOGY); NEUTROPENIA; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PROTEINURIA; RASH; SENSORY NEUROPATHY; SHORT SURVEY; SOMNOLENCE; SURVIVAL; SYNCOPE; THROMBOCYTOPENIA; TOXICITY; VEIN THROMBOSIS;

EID: 32544453248     PISSN: 03128008     EISSN: 03128008     Source Type: Journal    
DOI: 10.18773/austprescr.2006.008     Document Type: Short Survey

References (2)

1. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42.
2. Sandler AB, Gray R, Brahmer J, Dowlati A, Schiller JH, Perry MC, et al. Randomized phase II/III trial of paclitaxel (P) carboplatin (C) with or without bevacizumab (NSC # 704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group (ECOG) trial - E4599. Proceedings of the ASCO annual meeting; 2005 May 13-17; Orlando, USA.